Typical case of Tabes Dorsalis and Argyll Robertson pupils

Published On 2018-10-17 12:30 GMT   |   Update On 2018-10-17 12:30 GMT

Dr Chinar Osman, at the University of Southampton, Southampton, United Kingdom and colleagues have reported a typical case of Tabes Dorsalis and Argyll Robertson Pupils a manifestation of neurosyphilis. The case has appeared in NEJM.


Tabes dorsalis is a form of neurosyphilis with a slow demyelination of the neural tracts primarily in the dorsal columns (posterior columns) of the spinal cord and dorsal roots. These nerves normally help maintain a person's sense of position (proprioception), vibration, and discriminative touch. Along with Argyll Robertson pupils, the condition is associated with ataxia and loss of proprioception. Left untreated, tabes dorsalis can lead to paralysis, dementia, and blindness. Moreover, existing nerve damage cannot be reversed.


According to history, a 47-year-old man a known case of HIV infection presented with an 8-month history of severe paroxysmal shooting pains in his legs, progressive difficulty in walking, tinnitus, and urinary incontinence. He was on antiretroviral therapy and had a fully suppressed HIV viral load and a CD4+ count of 400 cells per cubic millimetre.



Courtesy NEJM


On examination, the patient demonstrated an Argyll Robertson pupils, which are nonreactive to bright light but briskly constrict when focusing on a near object. MRI revealed high signal changes in the dorsal columns of the thoracic spine, and samples of blood and cerebrospinal fluid were positive for syphilis VDRL testing and Treponema pallidum particle agglutination assay.
The patient was treated with intravenous penicillin for 14 days, and gabapentin was started for the neuropathic leg pains.


After treatment, the patient’s symptoms and mobility slowly improved, although the shooting pains in his legs have continued despite pharmacotherapy. The serum VDRL level fell appropriately, and the result on VDRL testing of the cerebrospinal fluid was negative.

Article Source : Press Release

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News